Petros Pharmaceuticals Inc(PTPI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PTPI Petros Pharmaceuticals Inc

Closed Good Friday 04-17 16:00:00 EDT

0.0410

+0.0009

+2.24%

盘后0.0420

+0.0010+2.44%

19:58 EDT

High0.0430	Low0.0402	Vol1.44M
Open0.0406	D1 Closing0.0401	Amplitude6.98%
Mkt Cap2.19M	Tradable Cap2.11M	Total Shares53.52M
T/O59.25K	T/O Rate2.80%	Tradable Shares51.44M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"PTPI","market":"US","secType":"STK","nameCN":"Petros Pharmaceuticals Inc","latestPrice":0.041,"timestamp":1744920000000,"preClose":0.0401,"halted":0,"volume":1440743,"hourTrading":{"tag":"盘后","latestPrice":0.042,"preClose":0.041,"latestTime":"19:58 EDT","volume":158421,"amount":6646.4533,"timestamp":1744934292524},"delay":0,"floatShares":51441028,"shares":53519045,"eps":-3.338777,"marketStatus":"Closed Good Friday","change":0.0009,"latestTime":"04-17 16:00:00 EDT","open":0.0406,"high":0.043,"low":0.0402,"amount":59254.97895601,"amplitude":0.069825,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.338777,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0401,"preHourTrading":{"tag":"盘前","latestPrice":0.0431,"preClose":0.0401,"latestTime":"09:24 EDT","volume":19814,"amount":854.8655985359999,"timestamp":1744896247049},"postHourTrading":{"tag":"盘后","latestPrice":0.042,"preClose":0.041,"latestTime":"19:58 EDT","volume":158421,"amount":6646.4533,"timestamp":1744934292524},"volumeRatio":0.46634755599308675,"impliedVol":4.4466,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/PTPI","defaultTab":"news","newsList":[{"id":"2527148444","title":"Toro Corp. reports Q4 EPS (1c) vs 36c last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2527148444","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527148444?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 21:06","pubTimestamp":1744722410,"startTime":"0","endTime":"0","summary":"Reports Q4 vessel revenue $5.2M vs $7.3M last year. Petros Panagiotidis, Chief Executive Officer of the Company, commented: “On April 14, 2025, we ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/toro-corp-reports-q4-eps-1c-vs-36c-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/toro-corp-reports-q4-eps-1c-vs-36c-last-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PTPI"],"gpt_icon":0},{"id":"2526647231","title":"Petros Pharmaceuticals Approves Key Amendments to Incorporation","url":"https://stock-news.laohu8.com/highlight/detail?id=2526647231","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526647231?lang=en_us&edition=full_marsco","pubTime":"2025-04-12 05:59","pubTimestamp":1744408768,"startTime":"0","endTime":"0","summary":"Petros Pharmaceuticals ( ($PTPI) ) just unveiled an announcement. On April 10, 2025, Petros Pharmaceuticals held a Special Meeting where stockholde...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/petros-pharmaceuticals-approves-key-amendments-to-incorporation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/petros-pharmaceuticals-approves-key-amendments-to-incorporation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTPI","BK4007"],"gpt_icon":0},{"id":"2524675364","title":"Petros Pharmaceuticals Full Year 2024 Earnings: US$3.34 loss per share (vs US$6.35 loss in FY 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524675364","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524675364?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 19:49","pubTimestamp":1743594569,"startTime":"0","endTime":"0","summary":"This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.NasdaqCM:PTPI Earnings and Revenue History April 2nd 2025. All figures shown in the chart above are for the trailing 12 month  period. Petros Pharmaceuticals shares are up 45% from a week ago.You should always think about risks. Case in point, we've spotted   5 warning signs for Petros Pharmaceuticals  you should be aware of.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/petros-pharmaceuticals-full-2024-earnings-114929323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PTPI"],"gpt_icon":1},{"id":"2520345746","title":"Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2520345746","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520345746?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 21:15","pubTimestamp":1742476500,"startTime":"0","endTime":"0","summary":"Company to integrate industry leading big data technology solutions into its AI-driven platform to expand capabilities in identifying eligible patients to receive formerly Rx medications over the counter. The Company's partner has developed an advanced, automated document capture and authentication system that leverages a patented global ID library to verify identity and eligibility. By analyzing an image of an ID card captured via computer or mobile device, the document capture tool ensures secure and reliable authentication to allow for access to a specific medication for which authentication is appropriate. The solution, when added to the Petros technology, will analyze an expansive international database to ensure the person's ID is authentic and corresponds to the actual patient, providing an additional level of confidence and safety.Petros is leading the way in its development of a proprietary technology-assisted platform that, based on multiple research studies, could help pharm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/petros-pharmaceuticals-partner-renowned-big-131500770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SWCH","BK4007","BK4513","LU1093756168.USD","BK4116","LU1093756325.SGD","PTPI"],"gpt_icon":0},{"id":"2514904690","title":"Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2514904690","media":"ACCESS Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514904690?lang=en_us&edition=full_marsco","pubTime":"2025-02-25 22:20","pubTimestamp":1740493200,"startTime":"0","endTime":"0","summary":"Proprietary technology utilizing AI and big data integrations to enable Rx to OTC switch candidates across multiple indications. Fady Boctor, Petros' President and Chief Commercial Officer, commented, \"This study supports our belief that, through this emerging technology, we can expand access of current Rx medications to OTC. The addition of AI and big data integration are key components to help optimize this access, and we are diligently creating a scalable Software as a Medical Device  approach, which we believe can significantly enhance the emerging self-care market.\". These results closely follow the recently adopted \"Nonprescription Drug Product with an Additional Condition for Nonprescription Use\"  rules by the United States Food and Drug Administration  for companies seeking Rx-to-OTC switch for pharmaceutical products. The Company's development activities, which are currently integrating additional technologies like AI and big data integration position Petros to be a key player","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/petros-pharmaceuticals-proprietary-technology-demonstrates-142000649.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LB","PTPI","BK4213","BK4233"],"gpt_icon":0},{"id":"2512665571","title":"Petros Pharmaceuticals Prices $9.6 Million Public Offering of Shares, Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2512665571","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512665571?lang=en_us&edition=full_marsco","pubTime":"2025-02-18 22:50","pubTimestamp":1739890241,"startTime":"0","endTime":"0","summary":"Petros Pharmaceuticals  said Tuesday it has priced a public offering of about 40 million shares, or pre-funded warrants, with each share accompanied by a Series A warrant to buy 0.25 share at an exercise price of $0.48 per 0.25 share, and a Series B warrant to buy one share at an exercise price of $0.48 per share.The combined public offering price of each share with the accompanying Series A warrant and Series B warrant is $0.24, and the combined public offering price of each pre-funded warrant together with the accompanying Series A warrant and Series B warrant is $0.2399, Petros said.The gross proceeds of the offering are expected to be $9.6 million, the company said.Net proceeds of the offering, expected to close on or about Wednesday, will be used for working capital and general corporae purposes, the company said.Price: 0.14, Change: -0.15, Percent Change: -51.19","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","PTPI"],"gpt_icon":0},{"id":"2512166397","title":"US Stocks Mixed; NY State Business Activity Rises In February","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166397","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512166397?lang=en_us&edition=full_marsco","pubTime":"2025-02-18 22:45","pubTimestamp":1739889914,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/02/43784079/us-stocks-mixed-ny-state-business-activity-rises-in-february","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX","BPTH","USJW.SI","PTPI","IE00B64PRP62.GBP","LU0061475181.USD","IE0034235188.USD","SQQQ","BK4585","KWE","TQQQ","BK4135","IE00BGHQF748.EUR","BK4187","TSYW.SI","MNQmain","LU1883839398.USD","NVIW.SI","SEPN","BK4588","NQmain","QID","QLD","USAW.SI",".IXIC","HCTI","LU1894683264.USD","BK4167","IE00B3QW5Z07.USD","PSQ","LU1894683348.USD","STT","BK4139","BK4007"],"gpt_icon":1},{"id":"2512816166","title":"Petros Pharmaceuticals prices 40M shares at 24c in public offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2512816166","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512816166?lang=en_us&edition=full_marsco","pubTime":"2025-02-18 22:40","pubTimestamp":1739889657,"startTime":"0","endTime":"0","summary":"Petros Pharmaceuticals (PTPI) announces the pricing of a public offering of approximately 40,000,000 shares of the Company’s common stock, par valu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/petros-pharmaceuticals-prices-40m-shares-at-24c-in-public-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/petros-pharmaceuticals-prices-40m-shares-at-24c-in-public-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PTPI"],"gpt_icon":0},{"id":"2512165481","title":"Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165481","media":"ACCESS Newswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512165481?lang=en_us&edition=full_marsco","pubTime":"2025-02-18 22:25","pubTimestamp":1739888700,"startTime":"0","endTime":"0","summary":"NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Petros Pharmaceuticals, Inc.  , a company focused on expanding consumer access to medication through over-the-counter  drug development programs, today announces the pricing of a public offering of approximately 40,000,000 shares of the Company's common stock , par value $0.0001 per share , with each share of Common Stock  accompanied by  a Series A Warrant to purchase 0.25 share of Common Stock at an exercise price of $0.48 per 0.25 share  and  a Series B Warrant to purchase one  share of Common Stock at an exercise price of $0.48 per share . The combined public offering price of each share of Common Stock together with the accompanying Series A Warrant and Series B Warrant is $0.24, and the combined public offering price of each pre-funded warrant together with the accompanying Series A Warrant and Series B Warrant is $0.2399, which represents the per share offering price for the Common Stock less the $0.0001 per share exercise pri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/petros-pharmaceuticals-announces-pricing-9-142500062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PTPI","BK4007"],"gpt_icon":0},{"id":"2510054118","title":"Malaysia’s Petronas to cut jobs to ensure survival: reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2510054118","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510054118?lang=en_us&edition=full_marsco","pubTime":"2025-02-07 12:23","pubTimestamp":1738902226,"startTime":"0","endTime":"0","summary":"Negotiations between Petronas and Sarawak’s Petros last year raised concerns over the impact on Petronas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/international/asean/malaysias-petronas-cut-jobs-ensure-survival-reports","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/international/asean/malaysias-petronas-cut-jobs-ensure-survival-reports","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["PTPI","BK4007"],"gpt_icon":0},{"id":"2506819825","title":"Petros Pharmaceuticals files to sell units, no amount given","url":"https://stock-news.laohu8.com/highlight/detail?id=2506819825","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506819825?lang=en_us&edition=full_marsco","pubTime":"2025-01-25 06:10","pubTimestamp":1737756610,"startTime":"0","endTime":"0","summary":"Dawson James Securities is exclusive placement agent. Published first on TheFly – the ultimate source for real-time, market-moving breaking financi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/petros-pharmaceuticals-files-to-sell-units-no-amount-given?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/petros-pharmaceuticals-files-to-sell-units-no-amount-given?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PTPI"],"gpt_icon":0},{"id":"2501200658","title":"Petros announces ‘conducive position’ with newly approved FDA OTC final rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2501200658","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501200658?lang=en_us&edition=full_marsco","pubTime":"2025-01-07 22:25","pubTimestamp":1736259929,"startTime":"0","endTime":"0","summary":"Petros Pharmaceuticals (PTPI) announces its conducive position in connection with the recently issued final rule, “Nonprescription Drug Product wit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/petros-announces-conducive-position-with-newly-approved-fda-otc-final-rules?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/petros-announces-conducive-position-with-newly-approved-fda-otc-final-rules?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTPI","BK4007"],"gpt_icon":0},{"id":"2501726200","title":"Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2501726200","media":"ACCESSWIRE","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501726200?lang=en_us&edition=full_marsco","pubTime":"2025-01-07 22:15","pubTimestamp":1736259300,"startTime":"0","endTime":"0","summary":"Proprietary technology developing quantum computing and applying AI to better enable Rx to OTC switch candidates across multiple indications. NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Petros Pharmaceuticals, Inc.  , a company focused on expanding consumer access to medication through over-the-counter  drug development programs, today announces its conducive position in connection with the recently issued final rule, \"Nonprescription Drug Product with an Additional Condition for Nonprescription Use\"  by the United States Food and Drug Administration  for companies seeking Rx-to-OTC switch for pharmaceutical products. The Company's recently announced shift in its primary business strategy was initially developed under guidance of earlier iterations of the rule, and the Company believes the final rule will help facilitate the development of its Software as a Medical Device  concept, which is designed to serve the emerging self-care market.Petros has developed a proprietary technology-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/petros-pharmaceuticals-strategically-positioned-benefit-141500364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","PTPI"],"gpt_icon":0},{"id":"2493647422","title":"Maxim Group Keeps Their Buy Rating on Petros Pharmaceuticals (PTPI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2493647422","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493647422?lang=en_us&edition=full_marsco","pubTime":"2024-12-21 02:02","pubTimestamp":1734717721,"startTime":"0","endTime":"0","summary":"In a report released on December 18, Naz Rahman from Maxim Group maintained a Buy rating on Petros Pharmaceuticals (PTPI – Research Report). The co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-keeps-their-buy-rating-on-petros-pharmaceuticals-ptpi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-keeps-their-buy-rating-on-petros-pharmaceuticals-ptpi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTPI"],"gpt_icon":0},{"id":"2492179398","title":"Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment”","url":"https://stock-news.laohu8.com/highlight/detail?id=2492179398","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492179398?lang=en_us&edition=full_marsco","pubTime":"2024-12-19 22:15","pubTimestamp":1734617700,"startTime":"0","endTime":"0","summary":"Company positions itself for new innovation utilizing AI and quantum computing to help expand patient access to drugs via OTC access. NEW YORK, NY / ACCESSWIRE / December 19, 2024 / Petros Pharmaceuticals, Inc.  , a company focused on expanding consumer access to medication through over the counter  drug development programs, today announced that in a recent podcast, The Intelligent Leadership Podcast, titled, \"The New Era of Healthcare, AI, Data and Consumer Empowerment,\" Petros President Fady Boctor discussed the Company's concerted efforts to develop its proprietary platform as a prospective technology driven Rx-to-OTC switch solution across a multitude of conditions and existing Rx only therapies.During the podcast, Boctor discussed Petros' technology tool development around a Drug Facts Label to self-select, as well as the utilization of AI to ensure safe engagement and access to a drug that has made the Rx-to-OTC switch. This previewed the Company's future strategic direction, de","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/petros-pharmaceuticals-featured-era-healthcare-141500841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4137","PTPI","BK4007","HCSG"],"gpt_icon":0},{"id":"2492797726","title":"Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2492797726","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492797726?lang=en_us&edition=full_marsco","pubTime":"2024-12-18 17:34","pubTimestamp":1734514462,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/24/12/42547912/why-corvus-pharmaceuticals-shares-are-trading-higher-by-around-22-here-are-20-stocks-moving-premarket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FSBW","BK4187","USJW.SI","BK4583","PRTG",".IXIC","SSBK","BK4020","COMM","WS","MNQmain","APDN","RR","BK4196","BK4006","BK4139","QID","SHLT","AUID","BK4590","QLD","BK4161","VSTE","PTPI","TQQQ","BK4121","BK4195","TSYW.SI","NUKK","USAW.SI","BK4211","SQQQ","EFSH","KWE","PSQ","BK4096","NQmain","PRZO","BK4023","TNXP","NIVF","BK4568","BK4157","CERO","CRVS","BK4007","NVIW.SI","BK4097"],"gpt_icon":1},{"id":"2492968548","title":"Petros to shift focus to development of tech as Rx-to-OTC switch solution","url":"https://stock-news.laohu8.com/highlight/detail?id=2492968548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492968548?lang=en_us&edition=full_marsco","pubTime":"2024-12-17 22:15","pubTimestamp":1734444951,"startTime":"0","endTime":"0","summary":"Petros Pharmaceuticals (PTPI) announces a shift in its corporate strategy to focus on the development of its proprietary technology platform as a p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/petros-to-shift-focus-to-development-of-tech-as-rx-to-otc-switch-solution?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/petros-to-shift-focus-to-development-of-tech-as-rx-to-otc-switch-solution?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTPI","BK4007"],"gpt_icon":0},{"id":"2492296594","title":"Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually","url":"https://stock-news.laohu8.com/highlight/detail?id=2492296594","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492296594?lang=en_us&edition=full_marsco","pubTime":"2024-12-17 22:00","pubTimestamp":1734444000,"startTime":"0","endTime":"0","summary":"Working to identify quantum computing partnerships to strengthen our AI technology to include critical health records to better enable Rx to OTC switch candidates across multiple indications. Fady Boctor, Petros' President and Chief Commercial Officer, commented, \"During the past few years, as we focused on bringing STENDRA from Rx-to-OTC, we developed a methodology using our technology platform that we believe would facilitate the execution of an Rx-to-OTC switch for a wide variety of prospective drugs. We think that the development of this technology, considering recent FDA and HHS policies, along with advancements in artificial intelligence and quantum computing, presents a more lucrative and lasting commercial opportunity for Petros' value potential.\". Petros has developed a proprietary technology-assisted platform that, based on multiple research studies, could help pharmaceutical companies pursue Rx-to-OTC switches. The Company believes that further advancement of this technology","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/proprietary-technology-addressing-rx-otc-140000217.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1093756168.USD","BK4007","SWCH","BK4513","PTPI","BK4116","LU1093756325.SGD"],"gpt_icon":0},{"id":"2490976820","title":"Petronas Concluded Talks Over Sarawak Gas Rights, Bernama Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2490976820","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490976820?lang=en_us&edition=full_marsco","pubTime":"2024-12-12 13:52","pubTimestamp":1733982723,"startTime":"0","endTime":"0","summary":"Malaysia’s Petroliam Nasional Bhd. has concluded talks with Sarawak over the Borneo state’s bid to claim its local gas distribution rights, according to a report by national news agency Bernama, citing Prime Minister Anwar Ibrahim.","market":"sg","thumbnail":"https://www.bnnbloomberg.ca/resizer/v2/3MS4EFA74TIXYUZV4FYVBOD2QU.jpg?smart=true&auth=ad82a3c98e4959fcd4a56640d093874c08f861bf8c62cb527f25d3a6d7c6293c&width=500&height=333","type":0,"news_type":0,"thumbnails":["https://www.bnnbloomberg.ca/resizer/v2/3MS4EFA74TIXYUZV4FYVBOD2QU.jpg?smart=true&auth=ad82a3c98e4959fcd4a56640d093874c08f861bf8c62cb527f25d3a6d7c6293c&width=500&height=333"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bnnbloomberg.ca/investing/2024/12/12/petronas-concluded-talks-over-sarawak-gas-rights-bernama-says/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bnn_bloomberg_highlight","symbols":["BK4007","PTPI"],"gpt_icon":0},{"id":"2490299877","title":"Malaysia PM Anwar says Petronas, Petros finalising deal on gas distribution in Sarawak","url":"https://stock-news.laohu8.com/highlight/detail?id=2490299877","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490299877?lang=en_us&edition=full_marsco","pubTime":"2024-12-12 09:08","pubTimestamp":1733965721,"startTime":"0","endTime":"0","summary":"MALAYSIAN oil firms Petroliam Nasional Berhad (Petronas) and Petroleum Sarawak Berhad (Petros) are finalising details on a long-delayed agreement over gas distribution...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/international/asean/malaysia-pm-anwar-says-petronas-petros-finalising-deal-gas-distribution-sarawak","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/international/asean/malaysia-pm-anwar-says-petronas-petros-finalising-deal-gas-distribution-sarawak","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["PTPI","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.petrospharma.com","stockEarnings":[{"period":"1week","weight":-0.1387},{"period":"1month","weight":-0.4384},{"period":"3month","weight":-0.8634},{"period":"6month","weight":-0.8719},{"period":"1year","weight":-0.9406},{"period":"ytd","weight":-0.8959}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products, including vacuum erection devices, PreBoost, VenoSeal, penile injections, and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals, Inc. is based in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.206546},{"month":2,"riseRate":0.2,"avgChangeRate":-0.12648},{"month":3,"riseRate":0.4,"avgChangeRate":-0.10363},{"month":4,"riseRate":0.2,"avgChangeRate":0.144033},{"month":5,"riseRate":0,"avgChangeRate":-0.186478},{"month":6,"riseRate":0.25,"avgChangeRate":-0.122343},{"month":7,"riseRate":0.25,"avgChangeRate":0.194818},{"month":8,"riseRate":0,"avgChangeRate":-0.244681},{"month":9,"riseRate":0.25,"avgChangeRate":-0.145412},{"month":10,"riseRate":0.25,"avgChangeRate":-0.081443},{"month":11,"riseRate":0.5,"avgChangeRate":0.09016},{"month":12,"riseRate":0.5,"avgChangeRate":0.011963}],"exchange":"NASDAQ","name":"Petros Pharmaceuticals Inc","nameEN":"Petros Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Petros Pharmaceuticals Inc(PTPI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Petros Pharmaceuticals Inc(PTPI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Petros Pharmaceuticals Inc,PTPI,Petros Pharmaceuticals Inc股票,Petros Pharmaceuticals Inc股票老虎,Petros Pharmaceuticals Inc股票老虎国际,Petros Pharmaceuticals Inc行情,Petros Pharmaceuticals Inc股票行情,Petros Pharmaceuticals Inc股价,Petros Pharmaceuticals Inc股市,Petros Pharmaceuticals Inc股票价格,Petros Pharmaceuticals Inc股票交易,Petros Pharmaceuticals Inc股票购买,Petros Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Petros Pharmaceuticals Inc(PTPI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Petros Pharmaceuticals Inc(PTPI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction